Profil
Eric Meldrum is currently the Chief Scientific Officer at ENYO Pharma SA and Citryll BV.
He previously held the position of Chief Scientific Officer at Calliditas Therapeutics Suisse SA.
Aktive Positionen von Eric Meldrum
| Unternehmen | Position | Beginn |
|---|---|---|
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutic products to treat autoimmune and other human diseases | Technik-/Wissenschafts-/F&E-Leiter | 29.08.2023 |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Eric Meldrum
| Unternehmen | Position | Ende |
|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutic products to treat autoimmune and other human diseases | Commercial Services |
















